These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18184092)

  • 1. Measuring HIV-1-specific T cell immunity: how valid are current assays?
    D'Souza MP; Altfeld M
    J Infect Dis; 2008 Feb; 197(3):337-9. PubMed ID: 18184092
    [No Abstract]   [Full Text] [Related]  

  • 2. T cells versus HIV-1: fighting exhaustion as well as escape.
    Robinson HL
    Nat Immunol; 2003 Jan; 4(1):12-3. PubMed ID: 12496971
    [No Abstract]   [Full Text] [Related]  

  • 3. Aiming for successful vaccine-induced HIV-1-specific cytotoxic T lymphocytes.
    Yang OO
    AIDS; 2008 Jan; 22(3):325-31. PubMed ID: 18195558
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunization with an HIV-1 immunogen induces CD4+ and CD8+ HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy.
    Valor L; Navarro J; Carbone J; Rodríguez-Sáinz C; Gil J; López F; Fernández-Cruz E;
    Vaccine; 2008 May; 26(22):2738-45. PubMed ID: 18433946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV/AIDS vaccines: 2007.
    Robinson HL
    Clin Pharmacol Ther; 2007 Dec; 82(6):686-93. PubMed ID: 17971817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV vaccines 1983-2003.
    McMichael AJ; Hanke T
    Nat Med; 2003 Jul; 9(7):874-80. PubMed ID: 12835708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T lymphocyte responses in HIV-1 infection: implications for vaccine development.
    Brander C; Walker BD
    Curr Opin Immunol; 1999 Aug; 11(4):451-9. PubMed ID: 10448136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New research in HIV immunity points way for vaccine.
    Rees J
    Immunotherapy; 2013 May; 5(5):445-6. PubMed ID: 23638739
    [No Abstract]   [Full Text] [Related]  

  • 9. Is an HIV vaccine possible?
    McMichael AJ; Hanke T
    Nat Med; 1999 Jun; 5(6):612-4. PubMed ID: 10371492
    [No Abstract]   [Full Text] [Related]  

  • 10. [HIV vaccination].
    Jablonowski H
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():68-9. PubMed ID: 19031568
    [No Abstract]   [Full Text] [Related]  

  • 11. New research in HIV immunity points way for vaccine.
    Rees J
    Expert Rev Clin Immunol; 2013 May; 9(5):403. PubMed ID: 23772447
    [No Abstract]   [Full Text] [Related]  

  • 12. Towards the development of a therapeutic vaccine for the treatment of HIV-1 infection: are we closer than ever?
    Egan MA
    Expert Rev Vaccines; 2007 Jun; 6(3):289-91. PubMed ID: 17542741
    [No Abstract]   [Full Text] [Related]  

  • 13. HIV vaccine efficacy trials: towards the future of HIV prevention.
    Kim D; Elizaga M; Duerr A
    Infect Dis Clin North Am; 2007 Mar; 21(1):201-17, x. PubMed ID: 17502236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic and functional characteristics of HIV-specific CD8 T cells and gag sequence variability after autologous dendritic cells based therapeutic vaccine.
    López A; van der Lubbe N; Sánchez-Palomino S; Arnedo M; Nomdedeu M; Castro P; Guilà M; Maleno MJ; García F; Gallart T; Gatell JM; Plana M
    Vaccine; 2009 Oct; 27(44):6166-78. PubMed ID: 19712765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One step forwards, one step back.
    Lifson JD; Martin MA
    Nature; 2002 Jan; 415(6869):272-3. PubMed ID: 11796990
    [No Abstract]   [Full Text] [Related]  

  • 16. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine.
    Liu J; Ngai N; Stone GW; Yue FY; Ostrowski MA
    Vaccine; 2009 Aug; 27(37):5077-84. PubMed ID: 19573639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. V3 CTL epitope density in a single recombinant molecule antigen differentially affects the number and activity of primary and memory CD8+ T cells.
    Lu L; Zhu Y; Diao J; Wang Z; Chen YH
    Vaccine; 2008 Feb; 26(6):845-52. PubMed ID: 18191003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTL to HIV-1: surrogates or sirens.
    Mathieson BJ
    Nat Med; 1995 Apr; 1(4):304-5. PubMed ID: 7585057
    [No Abstract]   [Full Text] [Related]  

  • 19. Developing an HIV cytotoxic T-lymphocyte vaccine: issues of CD8 T-cell quantity, quality and location.
    Masopust D
    J Intern Med; 2009 Jan; 265(1):125-37. PubMed ID: 19093965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of HIV-1-specific T cells by electroporation of T-cell receptor RNA.
    Hofmann C; Harrer T; Kubesch V; Maurer K; Metzner KJ; Eismann K; Bergmann S; Schmitt-Haendle M; Schuler G; Dörrie J; Schaft N
    AIDS; 2008 Aug; 22(13):1577-82. PubMed ID: 18670216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.